Gorillacillin and the Tragedy of the Commons
Was I right to prescribe an inferior medication to my patient?
(Read the rest and view comments at Critical Decisions)
Was I right to prescribe an inferior medication to my patient?
(Read the rest and view comments at Critical Decisions)
Such a no-brainer: If patients who receive care at Hospital A are more likely to get readmitted to the hospital 10, 20 or 30 days after discharge than patients in Hospital B, then Hospital A must be doing something wrong. Perhaps clinicians at that hospital are less adept at diagnosing and managing patients’ problems. Perhaps…
In the last few decades, medical schools have been teaching us doctors to inform patients about their treatment alternatives, so our patients can pick the alternative that best fits with their individual values. Which raises the question: Should doctors take the time to figure out the cost of treatment alternatives and communicate such information to…
Take a look at a brief summary of a new paper i just published, led by a wonderful medical student at Michigan, Michael Kozminski. It shows that oncologists seem to place far greater value on quantity of life over quality of life.
Imagine for a moment that you are an oncologist caring for a 53-year-old man with metastatic cancer, a person whose tumor has spread to lung and liver. With standard chemotherapy, this man can expect to live around 12 months. That standard treatment isn’t all that expensive in today’s terms, only $25,000 and his insurance company will pick up the entire tab since he is already maxed out on his yearly deductible and co-pays.
read more
“I can fix this.” The neurosurgeon was nothing if not confident. “The cyst is pushing on your spinal cord. If it continues to expand, it will damage your nerves and you may lose the ability to walk. But I can remove the cyst, and cure you.” The patient was a business school professor, a man…
Medical experts now agree that as a result of aggressive screening programs, we have an epidemic of cancer overdiagnosis in the United States. With mammograms finding tiny cancers and PSA tests discovering unpalpable prostate cancers, we are now unearthing some cancers too early for our own good. What do experts mean by “overdiagnosis,” you ask?…